Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02150460
Other study ID # NECKAD/TRIALS/001/2012
Secondary ID
Status Completed
Phase Phase 4
First received May 26, 2014
Last updated March 15, 2015
Start date October 2012
Est. completion date June 2013

Study information

Verified date May 2014
Source National Eye Centre, Kaduna
Contact n/a
Is FDA regulated No
Health authority Nigeria: National Agency For Food and Drug Administration and Control
Study type Interventional

Clinical Trial Summary

The aim of the study was to compare the efficacy and safety of single injection peribulbar anaesthesia against the classic double injection technique.

This was a double blind randomized controlled trial involving two groups of consenting, adult Nigerian subjects with operable age-related cataract. An anaesthetic nurse who allocated the subjects to the two groups administered all the injections. The same surgeon operated on all the subjects while the principal investigator and a research assistant measured the outcome variables. All others were blinded as to subject allocation.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 2013
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Age 50 years and above

- Diagnosed with uncomplicated senile cataract

- Visual acuity of <3/60

Exclusion Criteria:

- Impaired mental status

- Difficulty in speaking

- Known allergy to amide-type local anaesthetic agents and/ or hyaluronidase

- Previous surgery in the same eye

- Glaucoma

- Impaired ocular motility

- Eyelid abnormalities

- Patients with only one eye

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
One-site peribulbar injection
injection into the inferior medial orbital compartment
Two- site peribulbar injection
Two injections into the infero-temporal and supero-nasal orbital compartments

Locations

Country Name City State
Nigeria National Eye Centre Kaduna

Sponsors (1)

Lead Sponsor Collaborator
National Eye Centre, Kaduna

Country where clinical trial is conducted

Nigeria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time Taken to Achieve Adequate Akinesia Time taken to achieve akinesia and anesthesia adequate for surgery. Ability to move the eye in each of four directions (up, down, right and left) was scored thus: 2- normal movement, 1- reduced movement and 0- flicker or no movement. Upper eyelid akinesia was scored as 2- normal opening, 1- reduced movement and 0- complete immobility. Maximum score of 10 and minimum of 0. Adequate akinesia was defined as a total score of <4 and was evaluated at 10 and 15 minutes. 10 minutes and 15 minutes No
Primary Supplementary Injection(s) After 10 minutes if akinesia score was more than 3, supplementary injections were given and the effect assessed was 5 minutes later 5 minutes No
Primary Complications of Local Anaesthetic Injection Systemic complications: dyspnoea, bronchospasm, impaired consciousness, intravascular injection etc
Local complications: eyelid oedema, corneal oedema, conjunctival chemosis, conjunctival haemorrhage, globe perforation, vitreous haemorrhage, orbital haemorrhage etc
0,10 and 15 minutes Yes
Primary Pain Score for Local Anaesthetic Injection Pain was scored using a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain 20 minutes No
Primary Pain Score for Cataract Surgery Pain was scored on a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain 20 minutes No
Secondary Volume of Anaesthetic Drug (ml) Total volume of anaesthetic drug injected into the orbit to achieve anaesthesia and akinesia adequate for cataract surgery 10 and 15 minutes Yes
Secondary Total Number of Injections Total number of injections required to achieve an akinesia score of <4 15 minutes Yes
Secondary Surgeon Satisfaction Score for Local Anaesthetic Block Surgeon subjectively scored satisfaction with the anaesthetic block on a 4 point scale: 1- poor (25%), 2 - fair (50%), 3 - good (75%), 4 - excellent (100%) 20 minutes No
Secondary Acceptability of the Anaesthetic Block to the Subject Subjects were asked if they would agree to have the same anaesthetic procedure the next time they needed cataract surgery in the other eye 25 minutes No
Secondary Duration of Cataract Surgery (Minutes) Time interval from conjunctival incision to application of eye pad At the end of surgery No
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A